Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 2/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MPI | P34949 | 1/20 | 0.41 |
| ▸ | GFER | P55789 | 1/20 | 0.41 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.41 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25278236 | 0.86 | NPC1 (0.41) | PDE4ACYP19A1ALDH1A1HPGDMAPK1 | |
| SCHEMBL1680192 | 0.77 | ME2 (0.43) | ALDH1A1MAPK1KDM4EMEN1KMT2A | |
| SCHEMBL433808 | 0.75 | DYRK1A (0.49) | KDM4EKMT2ASMN1; SMN2NPC1RAB9A | |
| Hydrochloric Acid SCHEMBL15769036 | 0.74 | ME2 (0.41) | ALDH1A1MAPK1KDM4EMEN1KMT2A | |
| SCHEMBL498496 | 0.73 | CYP1B1 (0.42) | ALDH1A1HPGDKDM4ESMN1; SMN2NPC1 | |
| SCHEMBL8840880 | 0.72 | PDE4A (0.67) | PDE4AALDH1A1HPGDMAPK1KDM4E | |
| SCHEMBL5011965 | 0.71 | FABP4 (0.42) | ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL5016673 | 0.71 | FABP4 (0.42) | ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL4265254 | 0.70 | CYP1A2 (0.41) | ALDH1A1HPGDMAPK1KDM4EMEN1 | |
| SCHEMBL10570890 | 0.70 | ALDH1A1 (0.44) | ALDH1A1HPGDMAPK1KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9867800-B2 | Method of quenching singlet and triplet excited states of pigments, such as porphyrin compounds, particularly protoporphyrin IX, with conjugated fused tricyclic compounds have electron withdrawing groups, to reduce generation of reactive oxygen species, particularly singlet oxygen | HALLSTAR INNOVATIONS CORP. (US) | 2018-01-16 | — | — | US | claimed |
| US-20150164852-A1 | METHOD OF QUENCHING SINGLET AND TRIPLET EXCITED STATES OF PIGMENTS, SUCH AS PORPHYRIN COMPOUNDS, PARTICULARLY PROTOPORPHYRIN IX, WITH CONJUGATED FUSED TRICYCLIC COMPOUNDS HAVE ELECTRON WITHDRAWING GROUPS, TO REDUCE GENERATION OF REACTIVE OXYGEN SPECIES, PARTICULARLY SINGLET OXYGEN | HALLSTAR INNOVATIONS CORP. (US) | 2015-06-18 | — | — | US | claimed |
| WO-2014025370-A1 | TRICYCLIC ENERGY QUENCHER COMPOUNDS FOR REDUCING SINGLET OXYGEN GENERATION | HALLSTAR INNOVATIONS CORP. (US) | 2014-02-13 | — | — | WO | claimed |
| US-12071498-B2 | Radically polymerizable compositions | Polynt Composites USA, Inc. (US) | 2024-08-27 | — | — | US | disclosed |
| CN-113474383-B | Free radical polymerizable composition | 波林复合材料美国股份有限公司 | 2023-10-31 | — | — | CN | disclosed |
| US-20230257500-A1 | RADICALLY POLYMERIZABLE COMPOSITIONS | BNY MELLON CORPORATE TRUSTEE SERVICES LIMITED, AS SECURITY AGENT (GB) | 2023-08-17 | — | — | US | disclosed |
| US-11518834-B2 | Radically polymerizable compositions | Polynt Composites USA, Inc. (US) | 2022-12-06 | — | — | US | disclosed |
| EP-3077467-B1 | DRIER COMPOSITION AND USE THEREOF | PPG EUROPE B V (NL) | 2022-11-02 | — | — | EP | disclosed |
| EP-3906265-A1 | RADICALLY POLYMERIZABLE COMPOSITIONS | Polynt Composites USA Inc. (US) | 2021-11-10 | — | — | EP | disclosed |
| CN-113474383-A | Radically polymerizable composition | 波林复合材料美国股份有限公司 | 2021-10-01 | — | — | CN | disclosed |
| WO-2020142632-A1 | RADICALLY POLYMERIZABLE COMPOSITIONS | Polynt Composites USA, Inc. (US) | 2020-07-09 | — | — | WO | disclosed |
| US-20100041133-A1 | Biological targeting compositions and methods of using the same | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-02-18 | — | — | US | disclosed |
| US-20100042072-A1 | Biological targeting compositions and methods of using the same | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-02-18 | — | — | US | disclosed |
| US-20100041014-A1 | Biological targeting compositions and methods of using the same | ENTERPRISE SCIENCE FUND, LLC | 2010-02-18 | — | — | US | disclosed |
| US-20070086973-A1 | Drug delivery systems for photodynamic therapy | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2007-04-19 | — | — | US | disclosed |
| EP-1450790-A4 | PHOTOSENSITIZING CARBAMATE DERIVATIVES | MIRAVANT PHARM INC (US) | 2005-10-26 | — | — | EP | disclosed |
| US-20040266748-A1 | Photosensitizing carbamate derivatives | MIRAVANT PHARMACEUTICALS, INC. | 2004-12-30 | — | — | US | disclosed |
| EP-1450790-A2 | PHOTOSENSITIZING CARBAMATE DERIVATIVES | Miravant Pharmaceuticals, Inc. (US) | 2004-09-01 | — | — | EP | disclosed |
| US-6609014-B1 | Use of PDT to inhibit intimal hyperplasia | QLT INC. (CA) | 2003-08-19 | — | — | US | disclosed |
| WO-2003028628-A2 | PHOTOSENSITIZING CARBAMATE DERIVATIVES | MIRAVANT PHARMACEUTICALS, INC. (US) | 2003-04-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070086973-A1 | Drug delivery systems for photodynamic therapy | PIN1, PPOX, DHFR | PDE4A 1860/4885CYP19A1 1171/4885ALDH1A1 701/4885 |
| US-20150164852-A1 | METHOD OF QUENCHING SINGLET AND TRIPLET EXCITED STATES OF PIGMENTS, SUCH AS PORPHYRIN COMPOUNDS, PARTICULARLY PROTOPORPHYRIN IX, WITH CONJUGATED FUSED TRICYCLIC COMPOUNDS HAVE ELECTRON WITHDRAWING GROUPS, TO REDUCE GENERATION OF REACTIVE OXYGEN SPECIES, PARTICULARLY SINGLET OXYGEN | NOX3, CBR3, CCR3 | PDE4A 4349/4885CYP19A1 4373/4885ALDH1A1 2828/4885 |
| US-20040266748-A1 | Photosensitizing carbamate derivatives | CRY1, CASP3, CRY2 | PDE4A 1969/4885CYP19A1 1980/4885ALDH1A1 2202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.